Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes

Documenti analoghi

• Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
  di: Willemse, Eline A. J., et al.
  Pubblicazione: (2021)
• Combination of plasma amyloid beta((1-42/1-40)) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
  di: Verberk, Inge M. W., et al.
  Pubblicazione: (2020)
• A more randomly organized grey matter network is associated with deteriorating language and global cognition in individuals with subjective cognitive decline
  di: Verfaillie, Sander C. J., et al.
  Pubblicazione: (2018)
• Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe Project
  di: Verfaillie, Sander C. J., et al.
  Pubblicazione: (2019)
• Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
  di: van Steenoven, Inger, et al.
  Pubblicazione: (2019)